Cholangiocarcinoma Market Size, Share & Trends Analysis Report By Cancer Type (Intrahepatic CCA, Extrahepatic CCA), By Treatment Type (Chemotherapy, Immunotherapy, Targeted therapy, Radiation Therapy, Surgical Treatment, Palliative Care), By Biomarker (FGFR2, IDH1, BRAF, HER2, NTRK, RET) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: November 13, 2026 | Author: Straits Research Team | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Cholangiocarcinoma Market Size Analysis
    1. Introduction
    2. Cholangiocarcinoma Market Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
      1. Intrahepatic CCA
      2. Extrahepatic CCA
    3. Cholangiocarcinoma Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. Chemotherapy
      2. Immunotherapy
      3. Targeted therapy
      4. Radiation Therapy
      5. Surgical Treatment
      6. Palliative Care
    4. Cholangiocarcinoma Market Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
      1. FGFR2
      2. IDH1
      3. BRAF
      4. HER2
      5. NTRK
      6. RET
  7. North America Cholangiocarcinoma Market Size Analysis
    1. Introduction
    2. Cholangiocarcinoma Market Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
      1. Intrahepatic CCA
      2. Extrahepatic CCA
    3. Cholangiocarcinoma Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. Chemotherapy
      2. Immunotherapy
      3. Targeted therapy
      4. Radiation Therapy
      5. Surgical Treatment
      6. Palliative Care
    4. Cholangiocarcinoma Market Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
      1. FGFR2
      2. IDH1
      3. BRAF
      4. HER2
      5. NTRK
      6. RET
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
  8. Europe Cholangiocarcinoma Market Size Analysis
    1. Introduction
    2. Cholangiocarcinoma Market Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
      1. Intrahepatic CCA
      2. Extrahepatic CCA
    3. Cholangiocarcinoma Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. Chemotherapy
      2. Immunotherapy
      3. Targeted therapy
      4. Radiation Therapy
      5. Surgical Treatment
      6. Palliative Care
    4. Cholangiocarcinoma Market Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
      1. FGFR2
      2. IDH1
      3. BRAF
      4. HER2
      5. NTRK
      6. RET
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    7. France
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
  9. APAC Cholangiocarcinoma Market Size Analysis
    1. Introduction
    2. Cholangiocarcinoma Market Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
      1. Intrahepatic CCA
      2. Extrahepatic CCA
    3. Cholangiocarcinoma Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. Chemotherapy
      2. Immunotherapy
      3. Targeted therapy
      4. Radiation Therapy
      5. Surgical Treatment
      6. Palliative Care
    4. Cholangiocarcinoma Market Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
      1. FGFR2
      2. IDH1
      3. BRAF
      4. HER2
      5. NTRK
      6. RET
    5. China
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    8. India
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
  10. Middle East and Africa Cholangiocarcinoma Market Size Analysis
    1. Introduction
    2. Cholangiocarcinoma Market Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
      1. Intrahepatic CCA
      2. Extrahepatic CCA
    3. Cholangiocarcinoma Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. Chemotherapy
      2. Immunotherapy
      3. Targeted therapy
      4. Radiation Therapy
      5. Surgical Treatment
      6. Palliative Care
    4. Cholangiocarcinoma Market Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
      1. FGFR2
      2. IDH1
      3. BRAF
      4. HER2
      5. NTRK
      6. RET
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
  11. LATAM Cholangiocarcinoma Market Size Analysis
    1. Introduction
    2. Cholangiocarcinoma Market Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
      1. Intrahepatic CCA
      2. Extrahepatic CCA
    3. Cholangiocarcinoma Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. Chemotherapy
      2. Immunotherapy
      3. Targeted therapy
      4. Radiation Therapy
      5. Surgical Treatment
      6. Palliative Care
    4. Cholangiocarcinoma Market Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
      1. FGFR2
      2. IDH1
      3. BRAF
      4. HER2
      5. NTRK
      6. RET
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Cancer Type 2025-2034 (USD MILLION/ Units)
        1. Intrahepatic CCA
        2. Extrahepatic CCA
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Immunotherapy
        3. Targeted therapy
        4. Radiation Therapy
        5. Surgical Treatment
        6. Palliative Care
      4. Market Size & Forecast By Biomarker 2025-2034 (USD MILLION/ Units)
        1. FGFR2
        2. IDH1
        3. BRAF
        4. HER2
        5. NTRK
        6. RET
  12. Competitive Landscape
    1. Cholangiocarcinoma Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Incyte Corporation (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AstraZeneca PLC (UK)
    3. Merck & Co., Inc. (US)
    4. F. Hoffmann-La Roche Ltd. (Switzerland)
    5. Servier (France)
    6. Taiho Pharmaceutical Co., Ltd. (Japan)
    7. Bristol Myers Squibb Company (US)
    8. Bayer AG (Germany)
    9. Eisai Co., Ltd. (Japan)
    10. BeiGene Ltd. (Switzerland)
    11. Ono Pharmaceutical Co., Ltd. (Japan)
    12. Daiichi Sankyo Company, Limited (Japan)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Cholangiocarcinoma Market Size and Forecast By Regions - 2022-2034 (USD USD Billion)

Table 2: Global Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 3: Global Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 4: Global Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 5: North America Cholangiocarcinoma Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 6: North America Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 7: North America Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 8: North America Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 9: U.S. Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 10: U.S. Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 11: U.S. Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 12: Canada Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 13: Canada Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 14: Canada Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 15: Europe Cholangiocarcinoma Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 16: Europe Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 17: Europe Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 18: Europe Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 19: U.K. Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 20: U.K. Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 21: U.K. Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 22: Germany Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 23: Germany Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 24: Germany Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 25: France Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 26: France Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 27: France Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 28: Spain Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 29: Spain Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 30: Spain Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 31: Italy Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 32: Italy Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 33: Italy Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 34: Russia Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 35: Russia Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 36: Russia Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 37: Nordic Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 38: Nordic Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 39: Nordic Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 40: Benelux Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 41: Benelux Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 42: Benelux Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 43: Rest of Europe Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 44: Rest of Europe Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 45: Rest of Europe Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 46: APAC Cholangiocarcinoma Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 47: APAC Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 48: APAC Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 49: APAC Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 50: China Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 51: China Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 52: China Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 53: Korea Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 54: Korea Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 55: Korea Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 56: Japan Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 57: Japan Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 58: Japan Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 59: India Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 60: India Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 61: India Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 62: Australia Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 63: Australia Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 64: Australia Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 65: Taiwan Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 66: Taiwan Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 67: Taiwan Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 68: South East Asia Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 69: South East Asia Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 70: South East Asia Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 71: Rest of Asia-Pacific Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 72: Rest of Asia-Pacific Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 73: Rest of Asia-Pacific Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 74: Middle East and Africa Cholangiocarcinoma Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 75: Middle East and Africa Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 76: Middle East and Africa Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 77: Middle East and Africa Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 78: UAE Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 79: UAE Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 80: UAE Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 81: Turkey Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 82: Turkey Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 83: Turkey Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 84: Saudi Arabia Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 85: Saudi Arabia Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 86: Saudi Arabia Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 87: South Africa Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 88: South Africa Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 89: South Africa Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 90: Egypt Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 91: Egypt Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 92: Egypt Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 93: Nigeria Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 94: Nigeria Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 95: Nigeria Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 96: Rest of MEA Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 97: Rest of MEA Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 98: Rest of MEA Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 99: LATAM Cholangiocarcinoma Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 100: LATAM Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 101: LATAM Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 102: LATAM Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 103: Brazil Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 104: Brazil Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 105: Brazil Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 106: Mexico Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 107: Mexico Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 108: Mexico Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 109: Argentina Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 110: Argentina Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 111: Argentina Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 112: Chile Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 113: Chile Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 114: Chile Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 115: Colombia Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 116: Colombia Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 117: Colombia Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

Table 118: Rest of LATAM Cholangiocarcinoma Market Size and Forecast By Cancer Type - 2022-2034 (USD USD Billion)

Table 119: Rest of LATAM Cholangiocarcinoma Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 120: Rest of LATAM Cholangiocarcinoma Market Size and Forecast By Biomarker - 2022-2034 (USD USD Billion)

We are featured on: